Showing 11-20 of 23 grants

Title Institution Researcher Program Duration Total Award Amount
Market Analysis of Devices Utilized By Patients With T1D & Eligibility For Future T1D Cell and Gene Therapies Milliman Rebecca Smith Cures 01-January-2025 to 31-October-2025 $380,000.00
Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps Milliman Rebecca Smith Transportfolio 01-January-2025 to 01-October-2025 $545,000.00
Autoimmune stem-like T cells in type 1 diabetes Memorial Sloan-Kettering Cancer Center Andrea Schietinger Cures 01-September-2023 to 31-August-2026 $750,000.00
Bringing Beta Cell Regenerative Therapy to the Clinic Icahn School of Medicine at Mount Sinai Andrew Stewart Cures 01-January-2024 to 31-December-2026 $1,000,000.00
The KQ1 serum study: amendment & extension Icahn School of Medicine at Mount Sinai Dirk Homann Cures 01-November-2024 to 31-October-2027 $1,873,290.24
Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas Icahn School of Medicine at Mount Sinai Dirk Homann Cures 01-June-2024 to 31-May-2026 $145,989.21
Exploring the Effects of Beta Cell Regenerative Drugs on Cell Fate Decisions in Human Pancreatic Islets Icahn School of Medicine at Mount Sinai Esra Karakose Cures 01-March-2025 to 28-February-2030 $999,999.00
Enhancing Functional Maturation of Stem Cell-Derived Beta Cells Using Harmine for Improved Diabetes Therapy Icahn School of Medicine at Mount Sinai Peng Wang Cures 01-July-2025 to 30-June-2026 $305,000.00
Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-April-2025 to 31-March-2027 $559,996.54
Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy Icahn School of Medicine at Mount Sinai Susmita Sahoo Improving Lives 01-April-2025 to 31-March-2026 $199,998.24